*Lincoln Pharmaceuticals Ltd.* | *CMP* Rs. 345 | *M Cap* Rs. 689 Cr | *52 W H/L* 415/191
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 127.5 Cr (4.3% QoQ, 1.1% YoY) vs QoQ Rs. 122.2 Cr, YoY Rs. 126.1 Cr
EBIDTA came at Rs. 29.3 Cr (15.6% QoQ, -1.7% YoY) vs QoQ Rs. 25.3 Cr, YoY Rs. 29.8 Cr
EBITDA Margin came at 23% vs QoQ 20.7%, YoY 23.6%
Adj. PAT came at Rs. 23 Cr vs QoQ Rs. 17.7 Cr, YoY Rs. 20.9 Cr
Quarter EPS is Rs. 11.5
Share is trading at P/E of 10.3x TTM EPS